Zobrazeno 1 - 10
of 49
pro vyhledávání: '"Carlos Ferrer Albiach"'
Publikováno v:
Breast, Vol 60, Iss , Pp 255-262 (2021)
Introduction: Numerous prospective studies have shown that the incorporation of genomic assays into clinical practice significantly impacts the choice of adjuvant treatments for patients with early-stage breast cancer. However, the same evidence does
Externí odkaz:
https://doaj.org/article/34a937695973461ca48aa7a034ba64b6
Autor:
Ángel L. Sánchez-Iglesias, Virginia Morillo-Macías, Ana Santafé-Jiménez, Carlos Ferrer-Albiach
Publikováno v:
Radiation Oncology Journal. 40:192-199
Purpose: Ablative treatment of oligometastases has shown survival benefit with certain tumors, although these effects still are to be demonstrated in prostate cancer. Materials and Methods: We analysed the toxicity and clinical control results obtain
Autor:
Rodrigo Muelas-Soria, Rafael García-Mollá, Virginia Morillo-Macías, Jorge Bonaque-Alandí, Patricia Sorribes-Carreras, Francisco García-Piñón, Carlos Ferrer-Albiach
Publikováno v:
Biomedicines; Volume 10; Issue 6; Pages: 1401
The aim of this study was to develop a deformable image registration (DIR)-based offline ART protocol capable of identifying significant dosimetric changes in the first treatment fractions to determine when adaptive replanning is needed. A total of 2
Autor:
Falk Roeder, Philip Poortmans, Felipe A. Calvo, Ladan Saleh-Ebrahimi, Carlos Ferrer Albiach, Virginia Morillo
Publikováno v:
Radiotherapy and Oncology. 150:293-302
Purpose To describe guidelines for the use of intraoperative radiation therapy (IORT) in the treatment of soft-tissue sarcomas (STS). Methods A panel of experts in the field performed a systematic literature review, supplemented their clinical experi
Autor:
Encarnación Fernández-Camacho, Carlos Ferrer-Ramos, Virginia Morilllo-Macías, Marta Rodríguez-Cordón, Ángel Sánchez-Iglesias, Inmaculada Beato-Tortajada, Alicia Francés-Muñoz, Rodrigo Muelas-Soria, Teresa Piquer-Camañes, Ana Isabel Santafé-Jiménez, Vanessa Aznar-Tortonda, Carlos Ferrer-Albiach
Publikováno v:
Cancers; Volume 14; Issue 4; Pages: 1072
Background: Care overburden makes it difficult to perform comprehensive geriatric assessments (CGAs) in oncology settings. We analyzed if screening tools modified radiotherapy in oncogeriatric patients. Methods: Patients ≥ 65 years, irradiated betw
Publikováno v:
Bone Cancer ISBN: 9780128216668
Bone Cancer
Bone Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::949f8e47e6fa440c0bc13f032adad5ff
https://doi.org/10.1016/b978-0-12-821666-8.00026-8
https://doi.org/10.1016/b978-0-12-821666-8.00026-8
Autor:
Carlos Ferrer Albiach, C. Alix-Panabières, Fernanda Amary, Andrea Angelini, Gustavo A. Arias-Pinilla, Hector M. Arredondo Carrera, Sofia Avnet, Dominic Bagguley, Nicola Baldini, Jean-Yves Blay, Claudine Blin-Wakkach, Edith Bonnelye, Corinne Bouvier, J.V.M.G. Bovée, Mehdi Brahmi, Janet Brown, Thomas J. Brown, Janet E. Brown, Ø.S. Bruland, Teresa Piquer Camañes, Preston Campbell, Giovana Carrasco, Daniel Chappard, Michael M. Chau, Edward Chow, Dimitrios Christoulas, Anne-Marie Cleton-Jansen, Philippe Clézardin, Denis R. Clohisy, Denis Cochonneau, Robert Coleman, Nadege Corradini, Ovidiu Daescu, Heike Daldrup-Link, Dylan C. Dean, Gonzague de Pinieux, Zhenfeng Duan, Armelle Dufresne, Maryne Dupuy, A. Dutour, Claire M. Edwards, Jouglar Emmanuel, Fei Fei, Adrienne M. Flanagan, null Florent Elefteriou, Ramses Forsyth, Pierrick G.J. Fournier, Stefano Gambera, Dingcheng Gao, Javier García-Castro, Christopher George, Steven Georges, Anne Gomez-Brouchet, Francois Gouin, Agamemnon E. Grigoriadis, Arwin Groenewoud, Thomas G.P. Grünewald, Julia Halper, Yujiao Han, Shuko Harada, Jendrik Hardes, Jiri Hatina, Marie-Francoise Heymann, Dominique Heymann, David G. Hicks, L.S. Hiemcke-Jiwa, Tina Thi Ho, Pancras C.W. Hogendoorn, Ingunn Holen, Konstantin Horas, Francis J. Hornicek, Aymen I. Idris, Brenda I. Iduarte, Hakan Ilaslan, Victoria James, Prem Ruben Jayaram, Emmanuel Jouglar, Yan-Ran Joyce Wang, Patricia Juárez, A. Juzeniene, Yibin Kang, Mathijs Kint, Helen J. Knowles, Udo Kontny, Francois Lamoureux, R.H. Larsen, Mélanie Lavaud, Nathan Lawrentschuk, Michelle A. Lawson, Bénédicte Brounais Le-Royer, Patrick Leavey, Fernando Lecanda, Jiyun Lee, Mélanie Legrand, Frédéric Lézot, Shibo Li, Fiona Lim, Chun-Yu Lin, Andrej Lissat, Ana Lopez-Guajardo, Ollivier Luc, Joseph Ludwig, Jorma A. Määttä, Virginia Morillo Macías, Maria-Bernadette Madel, Paul I. Mallinson, Perrine Marec-Berard, Carina Marques, Ingrid Masson, Antonio Maurizi, Andreas F. Mavrogenis, Camila M. Melo, Sofía T. Menéndez, Nichole Michael, Himabindu Mikkilineni, Vivek Mittal, Sarah Morice, Peter L. Munk, Javier Muñoz-Garcia, Marcia A. Munoz, Ioannis Ntanasis-Stathopoulos, Oumaima Omran, Sean Ong, Benjamin Ory, Penelope D. Ottewell, Hugue A. Ouellette, Hui Pang, K. Pantel, Alexander H.G. Paterson, Ana Patiño-García, Peter Peneder, Tanguy Perennec, Margherita Puppo, Neiroshan Rajarubendra, Srinivas Raman, M.E. Revheim, I. Richert, Günther Richter, René Rodríguez, Michael J. Rogers, Nadia Rucci, Pietro Ruggieri, Lubaid Saleh, Markus J. Seibel, Gene P. Siegal, B. Ewa Snaar-Jagalska, Sofia Sousa, Jeremy A. Squire, Arne Streitbuerger, Murali Sundaram, Stéphane Supiot, Julie Talbot, Matthias Tallegas, Marta Téllez-Gabriel, Evangelos Terpos, Pichaya Thanindratarn, Erik W. Thompson, Roberto Tirabosco, Franck Tirode, Eleni M. Tomazou, Marcus Tötzl, Bradley M. Turner, Martin Valentine, Manoj K. Valluru, Gualter Vaz, Franck Verrecchia, Ning Wang, Shi Wei, Fern Wesson, Steven L. Wood, Liangcheng Henry Xu, Yet Yen Yan, Lidan You, Xiang H. -F. Zhang
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ee46c4bf7e143bcb3da3205c20b89b28
https://doi.org/10.1016/b978-0-12-821666-8.01002-1
https://doi.org/10.1016/b978-0-12-821666-8.01002-1
Autor:
María Dolores López Alarcón, Manuel Hernández Peris, Jorge Pastor Peidro, Carlos Ferrer Albiach, Ana Blasco Cordellat, Almudena Ruiz Sastre, Francisco Villegas Estévez, Alfonso Berrocal Jaime, Vicente Domingo Triado, Genoveva Hernández Comes, José López Torrecilla, Pilar Blasco Segura
Publikováno v:
Open Journal of Pain Medicine. 3:008-014
Objective: Breakthrough cancer pain (BTcP) is still underestimated and a percentage of patients are not adequately treated, affecting their quality of life. The aim of this review was to generate a series of expert recommendations based on clinical e
Autor:
Antonio Javier Jiménez López, Alfonso Carregal, Mª. Dolores López Alarcón, José Manuel Trinidad Martín-Arroyo, María de Madariaga, Carlos Ferrer Albiach, Javier Arranz, Francisco Villegas Estévez, Almudena Sanz Yagüe
Publikováno v:
Journal of Pain Research. 12:2125-2135
Purpose: We aimed to explore the characteristics, and real-life therapeutic management of patients with breakthrough cancer pain (BTcP) caused by bone metastases in Spain, and to evaluate physicians' opinion of and satisfaction with prescribed BTcP t
Autor:
Stephane OUDARD, David Olmos Hidalgo, María J. Ribal, Tomasz Drewa, ARANZAZU GONZALEZ-DEL-ALBA, Marcin Słojewski, Susan Ellard, Louis Lacombe, PABLO MAROTO REY, Javier Angulo, Adel Izmailov, Gwenaelle Gravis, Lisa Horvath, Boris Hadaschik, Ernesto Sanchez Sanchez, Florence Joly, Emmanuelle Bompas, Anders Kjellman, Hakim MAHAMMEDI, Arnauld VILLERS, Jose Luis Perez-Gracia, Carlos Ferrer Albiach
Publikováno v:
The New England Journal of Medicine, 378, 15, pp. 1408-1418
Poulsen, M H & SPARTAN Investigators 2018, ' Apalutamide treatment and metastasis-free survival in prostate cancer ', New England Journal of Medicine, vol. 378, no. 15, pp. 1408-1418 . https://doi.org/10.1056/NEJMoa1715546
The New England Journal of Medicine, 378, 1408-1418
Poulsen, M H & SPARTAN Investigators 2018, ' Apalutamide treatment and metastasis-free survival in prostate cancer ', New England Journal of Medicine, vol. 378, no. 15, pp. 1408-1418 . https://doi.org/10.1056/NEJMoa1715546
The New England Journal of Medicine, 378, 1408-1418
Contains fulltext : 193640.pdf (Publisher’s version ) (Open Access) BACKGROUND: Apalutamide, a competitive inhibitor of the androgen receptor, is under development for the treatment of prostate cancer. We evaluated the efficacy of apalutamide in me